News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.

1Amazon is Considering a $9 Billion Deal to Acquire Satellite Communications Company Globalstar. Here's Why Amazon, Apple, and Tesla Investors Should Pay Attention.2Exxon’s Guyana-Permian Engine Fuels 21% Earnings Growth—Is the 24 P/E Already Discounting a Squeeze?3Bitcoin’s Movement Compared to Oil’s Rally: Evaluating a Risk-Off Scenario

Fastly's 400%+ Rally: Debt Maturity Resolution and Trading Flow
101 finance·2026/03/18 19:18

Tiny AI Drone Tech Firm Soars 1,200% Within 48 Hours
101 finance·2026/03/18 19:18


Equinor Jumps More Than 3.2%: What’s Driving the Upward Trend?
101 finance·2026/03/18 19:15
Why Frontier (ULCC) Stock Is Dropping Sharply Today
101 finance·2026/03/18 19:13
Back-to-back Qualtrics, EA debt sales to test bond investors' appetites in volatile market
101 finance·2026/03/18 19:13

Prysmian’s 2027 Texas Facility: Capitalizing on Copper Shortages and the Data Center Boom
101 finance·2026/03/18 19:12

MDLZ Plummets Over 2.5%: What's Driving the Selloff in a Consumer Staples Titan?
101 finance·2026/03/18 19:12

Flash
20:17
According to the latest filings submitted to the U.S. Securities and Exchange Commission (SEC), global asset management giant BlackRock has successfully extended the maturity date of its revolving credit facility to March 31, 2031.This adjustment will apply to most lenders participating in this credit arrangement. The extension significantly enhances BlackRock's financial flexibility, providing stable funding support for its long-term strategic operations. As an important tool for short-term corporate financing, the extension of the revolving credit facility's maturity date helps optimize the company's liquidity management. Market observers point out that this move reflects BlackRock's robust financial condition and lenders’ continued confidence in its creditworthiness. In the current complex economic environment, such long-term financing arrangements lay a solid foundation for the sustainable development of enterprises.
20:17
AbbVie announced its full-year financial guidance for 2026According to the guidelines, after taking into account the impact of the acquisition of IPR&D (In-Process Research and Development projects with already obtained intellectual property) and milestone expenses occurring in the first quarter of 2026, the company expects full-year adjusted diluted earnings per share to be between $13.96 and $14.16.
20:17
According to the latest submitted documents, medical device company InspireMD Inc. has signed an equity distribution agreement with the sales agent.The agreement authorizes the company to issue and sell common stock with a total value of up to $75 million through an agent, using an at-the-market pricing mechanism. This financing arrangement will provide the company with a flexible channel for capital supplementation, supporting its future business operations and development plans. The specific quantity, timing, and price of the stock sales will be determined based on market conditions, the company's stock performance, and other factors.
News